The 17th Indian Premier B2B Medical Equipment Show (Medicall 2017) will be held in Chennai, the fourth largest city in India, from July 28 to July 30, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Ddu is going to focus on showcasing their online-to-offline promotional exhibition method along with the products of high priority members in India.
The Shanghai International Clinical Examination Equipment and Products Exhibition 2017 (CEEP) was held at the Shanghai World Expo Exhibition and Convention Center from July 13 to July 15, 2017. Ddu, the leading global pharmaceuticals and medical devices B2B online platform, attended Shanghai CEEP with products of high priority members and publically presented the Ddu app, receiving high praise.
WHO and the Population Division of the United Nations Department of Economic and Social Affairs have launched a new, open-access database of laws, policies and health standards on abortion in countries worldwide. The database aims to promote greater transparency of abortion laws and policies, as well as to improve countries’ accountability for the protection of women and girls’ health and human rights.
Malaysia represents one of the most vigorous and vibrant medical device markets in Southeast Asia, presenting opportunities for U.S. exporters of medical technology to expand their sales into rising economies. Increasing patient access to healthcare will remain in the focus of the Government of Malaysia for the next five years, to include upgrading facilities and equipment, and expanding delivery systems.
Dune Medical, which markets a tool that spots residual breast cancer cells following a lumpectomy, has raised $12.3 million. The funds will drive the development of the company’s technology for other types of cancer.
The 5th International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) was grandly held in Myanmar's capital, Yangon from July 5 - 7, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Drugdu.com (“Ddu”) participated in the exhibition and gaining an outstanding reputation from a number of exhibitors because of its business concept and service pattern.
A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including early stage tumor detection because of the enhanced MRI contrast, according to Dr. Han, associate professor of biochemistry & molecular pharmacology at University of Massachusetts Medical School.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.